European Academy of Dermatology and Venerology
Ended7 months ago More20 Oct 2011
VITILIGO PREVALENCE IN THE WORLD:
>3% *from 1 to 8% depending on region prevalenceThe Board of the VR Foundation thanks the Russian Society Of Dertmatovenerology for the support of World Vitiligo Day, which reflects their strong commitment to the future of...
The 58th Annual Howard Fox MD Memorial Lecture on March 13, 2012 provided by Torello M. Lotti MD, Professor and Vice Chancellor, Università degli Studi Guglielmo Marconi in...
British Journal of Dermatology Volume 166, Issue 3, pages 658–661, March 2012 Summary Background Vitiligo is a common acquired depigmentation disorder caused by the loss...
Author Information 1Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin Disorders, Hôpital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux,...
The Authors Torello Lotti, Jana Hercogova, Damiano Turini have the pleasure to invite you to the presentation of the book NATURAL ANTIOXIDANTS IN GENERAL MEDICINE AND...
Phototherapy using narrowband ultraviolet B (UVB) is considered among the treatments of choice in vitiligo, even in childhood. The objective of the current study was to evaluate...
Acta Derm Venereol. 2012 Feb 6 Department of Dermatology, University of Pavia, IRCCS-Polclinic S. Matteo Piazza C. Golgi, 2, IT-27100 Pavia,...
Deputy Scientific Director position in non-profit organization is available. Vitiligo Research Foundation (VRF) is a non-profit organization serving to promote vitiligo R&D,...
AN 18-YEAR-old from Penn has nearly fulfilled her ambition to climb the Seven Summits with just Everest left to face and has already broken a world record. Whilst raising money...
February 29, 2012 marks the fifth international Rare Disease Day coordinated by EURORDIS and organised with rare disease national alliances in 25 European countries.On this day...
"NLRP1, a regulator of innate immunity associated with vitiligo" (Andrea D’Osualdo and John C. Reed); "You have free access to this contentVitiligo as an inflammatory skin...
Vitiligo Research Foundation (VRF) in collaboration with Cosmetic Dermatology Society of India (CDSI) is proud to announce a call for grant proposals in vitiligo focused...
With shipping factors across borders in mind, we had determined how best to preserve samples at the collection point to provide the maximum downstream utility. Proteins and...
The VR Foundation is proud to announce an opening of the dedicated Vitiligo BioBank - a repository of genetic material from patients and related unaffected individuals,...
Author Information 1 Dermatology Department, Habib Thameur Hospital 2 Otolaryngology Department, Salah Azaÿz Institute. Faculty of Medicine, University of...
The Vitiligo Research Foundation is pleased to announce the results of the 2012 stipend competition and selection of the Winner for the most outstanding performance during the...
The first School on Pigmentary Disorders for this year was held in Barcelona between 2 and 5 of Novemder. 35 delegates from 26 countries attended, mostly from Europe, some from...
Author Information 1. Centre of Evidence Based Dermatology, University of Nottingham, Nottingham NG7 2NR, U.K. 2. Vitiligo Society, Cochran Skin Group, London,...
Abstract Background Human leucocyte antigen (HLA)-II alleles have been found to be associated with vitiligo in different populations, and several studies also suggested that...
"Dear Colleagues, It is our great pleasure and honour to invite you to Eleventh Congress of the European Society for Pediatric Dermatology (ESPD) organized by the Society of...
PRELIMINARY PROGRAM Speakers: Prof. Augustin Alomar (Spain) Prof. Jana Hercogova (Czech Republic) Prof. Torello Lotti (Italy) Dr. Yan Valle (Canada). Participants:...
Company Announcement Friday 21st October 2011 Melbourne, Australia First positive observations from Clinuvel's US vitiligo trial Clinuvel Pharmaceuticals Limited (ASX:...
"Vitiligo-pathogenetic concepts and treatment options" M. Picardo (Rome, Italy); Children with vitiligo onset after a new family member birth, M. Rodrigez Martin (Tenerife,...
Presented at the 19th Congress of the European Academy of Dermatology and Venereology, Gothenburg, Sweden, October 6-10, 2010. Electra Nicolaidou MD, PhD Corresponding Author...
Latest research efforts have improved our current knowledge of vitiligo and vitiligo patients. From the clinical standpoint, the Vitiligo European Task Force presented a...
http://ipcc2011.org/abstract/results
Most cases of vitiligo are acquired early in life with majority of patients showing the first symptoms of the disease before the age of 20 years. The prevalence of segmental...
Unlike the thoroughly investigated melanocyte population in the hair follicle of the epidermis, the growth and differentiation requirements of the melanocytes in the eye,...
Oral communication, S3 Seiji Memorial Lecture Official XXIst International Pigment Cell Conference website - 21-24 Sept 2011, Bordeaux - France | updated: September 04 2011 30...
INSPIRE program, a pilot phase 2 clinical trial, to test afamelanotide in patients with vitiligo 120 patients scheduled to be enrolled in the trial, with half receiving...
http://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/press.html Press Release 2011-10-03 The Nobel Assembly at Karolinska Institutet has today decided...
http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2011.00885.x/full
Nature Structural & Molecular Biology (2011) doi:10.1038/nsmb.2119 Received 27 May 2011 Accepted 08 July 2011 Published online 18 September...
09.09.2011 (WO2011108774) COMPOSITION FOR PREVENTING OR TREATING POLIOSIS OR VITILIGO COMPRISING A PUERARIA GENUS PLANT EXTRACT OR PUERARIN. Disclosed is a composition for...
"Although image-recognition software is still in its infancy, a number of mobile apps are already translating signs, naming landmarks and providing a running commentary on your...
Dear Colleagues, In today's competitive world of Dermatology, education and continuous training are the key to success and employability . Pigmentary Disorders of the skin are...
We have opened a section with articles. You are welcome!
Articles LibraryDue to Youtube limitations videos are cut to pieces. Sorry for unconvenience.
Videos Quick review EventsBy Yan Valle July 29, 2011 Firenze - VR Foundation released beta version of Cloud Medical Research And Management system, a bio-IT solution for discovery of correlations between...
Photos Quick review Events
The Symposium was a first public appearance of the VR Foundation since formal inception 6 months ago. Level of support to the formerly unknown Foundation from top scientific...
Call For Entries. The 2011 grant round for highly innovative Vitiligo research proposals is open until April 30, 2011.
MoreThe VRF proudly provides General Sponsorship to the II Continental Congress of Dermatology and IV Russian Congress of Dermavenerology, to be held in St....
Congress WebsiteJuly 7th, 2011. St. Petersburg, Russia
Preliminary Program Invitation LetterThe VR Foundation is developing a unique Cloud MRM – an environment to bridge the gap between scientific frontiers and the patients who need treatment. Its core mission...
Pre-registerThe non-profit VR Foundation accepts a variety of contributed material on vitiligo, melanoma and pigmentary disorders for possible inclusion on the website www.Vitinomics.net.
More...The 25June Initiative aims to increase awareness of vitiligo and raise funds for research, national vitiligo associations and support groups. Led by the VR Foundation, this year’s goal is to mark World Vitiligo Day on June 25 a date to be observed annually by the United Nations.
More...